Cargando…

Plasmapheresis for systemic vasculitis

Systemic vasculitides include a variety of, and numerous diseases. In 2012, the International CHAPEL HILL Consensus Conference (CHCC2012) led to a major reorganization of the classification of vasculitis, and this is still in wide use today. Although the results of plasmapheresis for individual dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuoka, Kazuhito, Kishimoto, Mitsumasa, Kawakami, Takahisa, Komagata, Yosinori, Kaname, Shinya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311821/ https://www.ncbi.nlm.nih.gov/pubmed/35247230 http://dx.doi.org/10.1111/1744-9987.13829

Ejemplares similares

Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2
por: Arikawa, Shigehisa, et al.
Publicado: (2022)

MPO-ANCA-positive Microscopic Polyangiitis Following COVID-19 Infection
por: Kawashima, Soko, et al.
Publicado: (2021)

Plasmapheresis in a Patient With "Refractory" Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report
por: Shibata, Yuko, et al.
Publicado: (2020)

587 Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis
por: Kartal, Ozgur, et al.
Publicado: (2012)

Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023)

Reactive arthritis after COVID-19 infection
por: Ono, Keisuke, et al.
Publicado: (2020)

Tenosynovitis with Rice Body Formation Due to Mycobacterium Intracellulare Infection After Initiation of Infliximab Therapy
por: Saraya, Takeshi, et al.
Publicado: (2018)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake
por: Fukuoka, Kazuhito, et al.
Publicado: (2017)

Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis
por: Ustuner, Pelin, et al.
Publicado: (2011)

A QUANTITATIVE TECHNIQUE FOR PERFORMING PLASMAPHERESIS
por: Melnick, Daniel, et al.
Publicado: (1936)

Plasmapheresis in Pediatric Intensive Care Unit
por: Misanovic, Verica, et al.
Publicado: (2016)

SUN-573 Plasmapheresis in Thyroid storm
por: Elmahboubi, Riham
Publicado: (2019)

Effectiveness of Plasmapheresis in Aluminum Phosphate Poisoning
por: Shariat, Shiva Samsam, et al.
Publicado: (2021)

Impact of plasmapheresis on severe COVID-19
por: Fonseca-González, G., et al.
Publicado: (2023)

Utility of Plasmapheresis in Autoimmune-Mediated Encephalopathy in Children: Potentials and Challenges
por: Khair, Abdulhafeez M.
Publicado: (2016)

Real‐world application of plasmapheresis for neurological disease: Results from the Japan‐Plasmapheresis Outcome and Practice Patterns Study
por: Lin, Youwei, et al.
Publicado: (2022)

Plasmapheresis and the immunobiology of myasthenia gravis : proceedings of a symposium /
Publicado: (1979)

Vasculitis in Systemic Sclerosis
por: Kao, Lily, et al.
Publicado: (2010)

Textbook of Systemic Vasculitis
por: Kohli, H. S.
Publicado: (2015)

Textbook of systemic vasculitis
por: Sharma, Amit, et al.
Publicado: (2017)

The Successful Application of Plasmapheresis in the Treatment of a Patient with Opsoclonus and Autoantibodies to Glutamate Receptor δ2
por: Nakamagoe, Kiyotaka, et al.
Publicado: (2017)

Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus.
por: Choi, M. Y., et al.
Publicado: (1993)

Unclassified Vasculitis with Episcleritis, Thrombophlebitis, Deep Vein Thrombosis, Pulmonary Vasculitis, and Intracranial Vasculitis: An Autopsy Case Report
por: Watanabe, Eri, et al.
Publicado: (2019)

Plasmapheresis as a viable treatment option for scleritis
por: Preble, Janine M., et al.
Publicado: (2022)

Adult-onset Satoyoshi syndrome and response to plasmapheresis
por: Aghoram, Rajeshwari, et al.
Publicado: (2016)

Salvage Plasmapheresis for Post-hepatectomy Liver Failure
por: Inayat, Faisal, et al.
Publicado: (2016)

Prospects of plasmapheresis for patients with severe COVID-19
por: Gilmutdinova, Ilmira R., et al.
Publicado: (2020)

Plasmapheresis for NMOSD: Not a Rescue Therapy Anymore!?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy
por: Maki, Yohei, et al.
Publicado: (2020)

Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis
por: Miller, Ann, et al.
Publicado: (2019)

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis
por: Fujita, Yuya, et al.
Publicado: (2018)

Role of Plasmapheresis and Extracorporeal Membrane Oxygenation in the Treatment of Leptospirosis Complicated with Pulmonary Hemorrhages
por: Fonseka, C. L., et al.
Publicado: (2018)

Pulmonary manifestations of systemic vasculitis in childhood
por: Lawton, Adam, et al.
Publicado: (2020)

Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report
por: Sofue, Tadashi, et al.
Publicado: (2014)

ODP487 Iatrogenic Thyroid Storm Treated with Plasmapheresis
por: Alam, Mustafa, et al.
Publicado: (2022)

Treating Hypertriglyceridemia-Induced Pancreatitis With Intravenous Insulin and Plasmapheresis
por: Ng, Lay She, et al.
Publicado: (2022)

Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Rogalewski, Andreas, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_089tcjrdmh1j3ognmts4ast21j